U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H22N6O3
Molecular Weight 418.4485
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FUTIBATINIB

SMILES

[H][C@@]1(CCN(C1)C(=O)C=C)N2N=C(C#CC3=CC(OC)=CC(OC)=C3)C4=C(N)N=CN=C24

InChI

InChIKey=KEIPNCCJPRMIAX-HNNXBMFYSA-N
InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1

HIDE SMILES / InChI

Molecular Formula C22H22N6O3
Molecular Weight 418.4485
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Targets
PubMed

PubMed

TitleDatePubMed
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
2019 Aug
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer.
2019 Dec
TAS-120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure.
2019 Feb 19
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:08:45 UTC 2023
Edited
by admin
on Sat Dec 16 09:08:45 UTC 2023
Record UNII
4B93MGE4AL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FUTIBATINIB
USAN   INN  
Official Name English
LYTGOBI
Brand Name English
Futibatinib [WHO-DD]
Common Name English
FUTIBATINIB [USAN]
Common Name English
futibatinib [INN]
Common Name English
FGFR-IN-1
Common Name English
TAS-120
Code English
FUTIBATINIB [JAN]
Common Name English
2-PROPEN-1-ONE, 1-((3S)-3-(4-AMINO-3-(2-(3,5-DIMETHOXYPHENYL)ETHYNYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-1-PYRROLIDINYL)-
Systematic Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/19/2146
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
FDA ORPHAN DRUG 635018
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
Code System Code Type Description
CAS
1814961-20-0
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
NO STRUCTURE GIVEN
FDA UNII
4B93MGE4AL
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
SMS_ID
100000180711
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
DAILYMED
4B93MGE4AL
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
USAN
GH-182
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
INN
10879
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
NCI_THESAURUS
C114283
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
DRUG BANK
DB15149
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
CAS
1448169-71-8
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
PUBCHEM
71621331
Created by admin on Sat Dec 16 09:08:45 UTC 2023 , Edited by admin on Sat Dec 16 09:08:45 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
TARGET -> INHIBITOR
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY